You just read:

Nobilis Therapeutics Announces IND Filing for a Phase IIb Clinical Trial of NBTX-001 Drug/Device Combination for Treatment of Posttraumatic Stress Disorder

News provided by

Nobilis Therapeutics Inc.

Jan 07, 2019, 04:00 ET